Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Genus plc
  6. Summary
    GNS   GB0002074580

GENUS PLC

(GNS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
10/14/2021 10/15/2021 10/18/2021 10/19/2021 10/20/2021 Date
5410(c) 5425(c) 5385(c) 5425(c) 5505 Last
639 133 109 667 49 146 91 944 55 595 Volume
-0.46% +0.28% -0.74% +0.74% +1.47% Change
More quotes
Estimated financial data (e)
Sales 2022 601 M 832 M 832 M
Net income 2022 55,2 M 76,3 M 76,3 M
Net Debt 2022 99,0 M 137 M 137 M
P/E ratio 2022 65,9x
Yield 2022 0,63%
Sales 2023 648 M 896 M 896 M
Net income 2023 65,7 M 90,9 M 90,9 M
Net Debt 2023 79,9 M 110 M 110 M
P/E ratio 2023 55,9x
Yield 2023 0,69%
Capitalization 3 524 M 4 870 M 4 874 M
EV / Sales 2022 6,02x
EV / Sales 2023 5,56x
Nbr of Employees 3 400
Free-Float 99,4%
More Financials
Company
Genus PLC is a United Kingdom-based animal genetics company. The Company provides farmers with genetics that enable them to produce animal protein for breeding pigs and cattle, in the form of meat and milk. The Company’s operating segments includes Genus PIC, Genus ABS and Research and Development. The Genus PIC segment is engaged in porcine sales busines, excluding Asia, and serves porcine customers in North... 
Sector
Biotechnology & Medical Research
Calendar
11/18
More about the company
Ratings of Genus plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about GENUS PLC
09/24WALL STREET STOCK EXCHANGE : The day after tomorrow
09/24ANALYST RECOMMENDATIONS : Boohoo, Coca-Cola, Monster Beverage, Molson Coors, Philip Morris..
09/15GENUS : Liberum Lifts Genus' PT, Reiterates Buy Rating
MT
09/09GENUS : Peel Hunt Downgrades Genus To Hold From Buy, Keeps PT
MT
09/09FTSE Down, Hochschild Shares Expected to Rise as Investors Digest Rare Earths Project
DJ
09/09FTSE 100 Retreats Again as Travel, Retail Stocks Fall
DJ
09/09FTSE 100 records worst session in 3 weeks on stronger pound
RE
09/09GENUS : FY21 Profit Rises on Back of Porcine Genetics Revenue Growth
MT
09/09GENUS : Earnings Flash (GNS.L) GENUS Reports FY21 EPS GBX72.60
MT
09/09GENUS PLC : Reports Preliminary Results for the Year Ended 30 June 2021
BU
09/09Genus plc Recommends Final Dividend for the Year Ended 30 June 2021, Payable on 10 Dece..
CI
09/09Genus plc Reports Earnings Results for the Full Year Ended June 30, 2021
CI
09/09Genus plc acquired Trade and assets of Sergal Gestio Ramadera, S.L. from Sergal Gestio ..
CI
06/30Genus plc completed the acquisition of a 39% stake in Xelect Ltd for £2.4 million.
CI
06/22Genus Seeks Acquisitions
CI
More news
News in other languages on GENUS PLC
09/09Le bénéfice de Genus pour l'exercice 21 augmente grâce à la croissance des recettes de ..
09/09Genus plc recommande un dividende final pour l'exercice clos le 30 juin 2021, payable l..
2020Trois actions approuvées par nos amies les bêtes
More news
Analyst Recommendations on GENUS PLC
More recommendations
Chart GENUS PLC
Duration : Period :
Genus plc Technical Analysis Chart | GNS | GB0002074580 | MarketScreener
Technical analysis trends GENUS PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 5 425,00 GBX
Average target price 5 499,43 GBX
Spread / Average Target 1,37%
EPS Revisions
Managers and Directors
Stephen Wilson Chief Executive Officer & Executive Director
Alison Henriksen Chief Financial Officer & Director
Iain George Thomas Ferguson Non-Executive Chairman
Elena Rice Chief Scientific Officer
Bill Christianson Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
GENUS PLC29.29%4 863
MODERNA, INC.219.34%134 660
LONZA GROUP AG27.07%58 240
IQVIA HOLDINGS INC.38.99%47 715
SEAGEN INC.-0.54%31 691
CELLTRION, INC.-39.00%25 332